Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa

NCT00441298 is registered in ClinicalTrials.gov with Centre for the AIDS Programme of Research in South Africa as lead sponsor.

NCT NCT00441298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00441298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa
Lead sponsor
Centre for the AIDS Programme of Research in South Africa
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
March 31, 2010
Enrollment
889 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections